Oncology News

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca.

The University of Texas MD Anderson Cancer Center is pleased to announce that one of the world's preeminent experts in breast cancer research and treatment, V. Craig Jordan, Ph.D., will join the institution's efforts to end cancer.

Jordan Foster is only five years old, but her father told WAVY.com she saw ads about hosting lemonade stands for Anthem's LemonAid for Children's Miracle Network Hospitals and decided to participate.

Twenty years ago, Pam Roberts was diagnosed with breast cancer. Every week through treatment and rehabilitation, Roberts attended a writing workshop, where she found that no matter what prompt was given, she'd write about her experience with cancer.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the fourth quarter and fiscal year ended April 30, 2014, on Thursday, July 24, 2014, after market close.

This clinical trial is called STARTRK-1, which stands for A/B/C, and is a Phase I/IIa, multicenter, single-arm, open-label clinical trial of continuous daily dosing of oral RXDX-101 in adult patients with locally advanced or metastatic cancer confirmed to be positive for relevant molecular alterations.

In what's being described as a significant show of support for immunotherapy research in the treatment of cancer, the National Institutes of Health has awarded a $1.6 million, five-year grant to a Providence Cancer Center researcher.

Ballarat Regional Integrated Cancer Centre director Steve Medwell shows the facility to a delegation from Peter's Project in Warrnambool.

The monthly health care industry publication, Becker's Hospital Review , released its list of "500+ People to Know in Healthcare."

A breast cancer patient died after a delay of nearly two years in informing her of her positive test results.

Cancer survivor Randy Childress joked that the disease was a great weight loss program when he was sick in the late '90s, but 20 years of medical advances have continually improved the quality of life for survivors of the disease.

Breast cancer claims thousands of innocent lives across the globe every year. Based on the different stages of breast cancer, the doctors decide on the mode of treatment.

Like a lot of teen girls, Faith Brown has read The Fault in Our Stars, the popular novel about two teens who fall in love at a cancer support group.

Cancer Council Victoria is campaigning for improvements to the Victorian Patient Transport Assistance Scheme ahead of this year's Victorian election.

Dr. Ed Kim, chair of solid tumor oncology and investigational therapeutics at Carolinas HealthCare System's Levine Cancer Institute.

The NCCN Annual Conference: Advancing the Standard of Cancer Care, held March 13-15 2014, presents the latest cancer therapies and provides updates on selected NCCN Clinical Practice Guidelines in Oncology , the data upon which the NCCN Guidelines are based, and quality initiatives in oncology.

The American Society of Clinical Oncology will host their 50th Annual Meeting on May 30-June 3, 2014 in Chicago, Illinois.

James 1:2-4 Dear brothers and sisters, when troubles of any kind come your way, consider it an opportunity for great joy.

Words are powerful, and when spoken or written effectively and passionately by a person of prominence they can take on amplified meaning and become a beacon of awareness or a call to action.

Depression and other mental illnesses might keep some men from seeking or following treatment for prostate cancer, a new study shows.